HYPRHyperfine, Inc.
- BusinessWire
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced ...
- BusinessWire
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million
Preliminary Revenue Represents 53% Sequential Quarterly Growth; Company Reaffirms 2026 Financial Guidance and Expects Quarter-End Cash and Cash Equivalents of Approximately $37.9 Million Hyperfine, Inc. ...
- BusinessWire
Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets
Hyperfine has appointed Roots Pharmaceutical as exclusive distributor of the Swoop® system for Kuwait and the United Arab EmiratesHyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has ...
- Analyst Upgrades
BTIG Reiterates Buy on Hyperfine, Maintains $2 Price Target
BTIG analyst Marie Thibault reiterates Hyperfine with a Buy and maintains $2 price target. ...
- BusinessWire
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
The anticipated indication expansion would position Hyperfine to drive adoption in outpatient neurology and establish new opportunities for portable MRI in post-procedural imaging in operating room ...
- Analyst Upgrades
BTIG Reiterates Buy on Hyperfine, Maintains $2 Price Target
BTIG analyst Marie Thibault reiterates Hyperfine with a Buy and maintains $2 price target. ...
- BusinessWire
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced ...
- BusinessWire
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
This newest software delivers improved image quality across Swoop system sequences, a more intuitive scanning experience, and new foundational isotropic imaging designed to strengthen the clinical utility of portable ...
- Analyst Upgrades
B. Riley Securities Reiterates Buy on Hyperfine, Lowers Price Target to $1.6
B. Riley Securities analyst Yuan Zhi reiterates Hyperfine with a Buy and lowers the price target from $2 to $1.6. ...
- Earnings Call Transcripts
Hyperfine Q2 '26 Earnings Call - HYPERFINE INC
Good afternoon and welcome to Hyperfine's second quarter 2026 earnings conference call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, we will open the call for questions. ...
- BusinessWire
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® ...
- BusinessWire
Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care
Recent publications in the prominent Journal of Neurosurgery and Stroke provide new evidence supporting the clinical value of the Swoop system in stroke care and neurosurgical settings. Hyperfine, Inc. (NASDAQ:HYPR), ...
- BusinessWire
Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced ...
- BusinessWire
Hyperfine Announces European Launch of Next-Generation Swoop® System
Hyperfine has initiated the launch of the next-generation Swoop® system in European markets, beginning the global expansion of its most advanced portable MRI technology. Hyperfine, Inc. (NASDAQ:HYPR), the ...
- BusinessWire
Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care
Leading neurosurgeons from around the world will help guide the role of the Swoop® system in neurosurgical care, including surgical workflow, product capabilities, and clinical evidence. Hyperfine, Inc. ...
- BusinessWire
Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
Routine clinical use is accelerating, driven by advanced image quality, expanding clinical utility, and increasingly diverse use cases across hospital and office settings. Hyperfine, Inc. (NASDAQ:HYPR), the ...
- BusinessWire
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system— today ...
- BusinessWire
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
Prospective randomized ED study shows rapid bedside imaging, detection of critical neurological findings, and potential workflow efficiency benefits with portable MRI Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking ...
- Earnings Call Transcripts
Hyperfine Q1 '26 Earnings Call - HYPERFINE INC
Good afternoon, and welcome to the Hyperfine Quarter 1 2026 Earnings Call. I am Franz, and I'll be the operator assisting you today. All lines have been placed on mute to prevent any background noise. After the speaker's ...
- BusinessWire
Hyperfine, Inc. Reports First Quarter 2026 Financial Results
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® ...
- BusinessWire
Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced ...
- Analyst Upgrades
This Hyperfine Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday
Top analysts change outlook on Hyperfine Inc, Legence, and Aktis Oncology with Buy/Outperform ratings and price targets. See other analysts' views. ...
- BusinessWire
Hyperfine Swoop® System Introduced as India's First Portable MRI for Bedside Brain Imaging at the Country's Leading Medical Institution
The All India Institute of Medical Sciences, New Delhi, in partnership with Radiosurgery Global India, begins clinical use of the Hyperfine Swoop® portable MRI system Hyperfine, Inc. (NASDAQ:HYPR), the ...
- Analyst Upgrades
BTIG Initiates Coverage On Hyperfine with Buy Rating, Announces Price Target of $2
BTIG analyst Marie Thibault initiates coverage on Hyperfine with a Buy rating and announces Price Target of $2. ...
- BusinessWire
Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced ...